Press Releases
Apps & Digital Resources vie for top honour at...
Two thirds of the finalists for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona Awards have used interactive digital resources or mobile applications...
Press Releases
TxCell receives EU Orphan Drug Designation for Col-Treg in...
TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory...
Press Releases
CARLINA Technologies signs a partnership agreement with Atlangram to...
Angers, France, December 16, 2014 - CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement...
Press Releases
Evotec and Sanofi negotiate drug discovery collaboration and pre-clinical...
Germany-based Evotec is negotiating with French drugmaker Sanofi for a multi-component strategic collaboration over the next five years. The alliance...
Press Releases
Mylan and Gilead partner for TAF-based HIV treatments in...
Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. ...
Press Releases
Daiichi and UCB Biopharma partner to introduce epilepsy treatment...
Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan....
Press Releases
GSK seeks European approval for eltrombopag to treat severe...
British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.